By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.

Sunday, June 1, 2008

Erbitux adds 5 weeks to lung cancer survival (Reuters via Yahoo! News)

Lung cancer patients treated in a large clinical trial with ImClone Systems Inc's Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to study results released on Saturday.

No comments: